$0
0 item(s) in the shopping cart

Improve a company’s sustainability performance
By using the world’s most comprehensive CSR metrics database and analysis tools

Regeneron Pharmaceuticals, Inc. CSR Ratings

42
CSR Rating Compared To All Companies
?
Community
44
Employees
47
Environment
40
Governance
37
Low
0-29
30-39
40-49
50-59
60-79
80-100
High
?
CSR Rating History
This company vs 16,133 companies
The average for the 425 companies in the Pharmaceutical & Medicine Manufacturing industry
?

0 Special Issues

Affect This Company

?
24
Active Sources
25 Total Sources
?
Share This Summary

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has candidates in preclinical programs for other diseases and disorders. Regeneron has received marketing approval from the U.S. Food and Drug Administration for ARCALYST Injection for Subcutaneous Use for a rare inflammatory condition.

Ticker: REGN
ISIN: US75886F1075
Address:

777 Old Saw Mill River Road

  Tarrytown, NY, 10591, USA
Website: Regeneron Pharmaceuticals, Inc.
Phone #: 914-345-7400
CSR Web Area: Subscribers Only ?
Industry: Pharmaceutical & Medicine Manufacturing
PRIORITIES
Community
2.6
Employees
2.8
Environment
3.7
Governance
2.9
Edit your profiles
SWITCH PROFILE
Data Date
January 01, 2016
0 SPECIAL ISSUES SELECTED
CSRHub Subscribers Get Much More
CSRHub subscribers gain unparalleled and direct access to over 94 million data items, our easy-to-use suite of benchmarking and comparison tools, as well as our popular custom excel dashboards.
Access CSRHub's Premium Features